News
Of the 224 companies analyzed, 98 received a clinical robustness score of zero.
This follows last year's FDA approvals in the US.
Also: Oma Fertility emerges from stealth with $37.5 million in equity and debt financing, and payer data platform Abacus Insights scores $28 million.
Equip CEO and cofounder Kristina Saffran discusses the virtual eating disorder treatment startup's nationwide expansion and why the space needs more research and innovation.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
Also, Nordic nurse-tech pioneer to launch in the UK.
It will use the funds to deepen its presence across Asia.
The company has also launched a distribution unit in the United States.